Wound closure

Skin substitute LCDs withdrawn, spending concerns remain

Mon, 29 Dec 2025 11:00:00 -0500

The U.S. Centers for Medicare & Medicaid Services announced that several Medicare administrative contractors have formally withdrawn local coverage determinations for skin substitutes. There are questions, however, as to whether this will bring an end to excess spending on these products even though the agency has capped the rate paid for entire classes of products.

Solventum agrees to acquire Acera for up to $850M

Thu, 20 Nov 2025 11:00:00 -0500

Solventum Corp. continued its restructuring with a second significant acquisition this year, the proposed purchase of privately held Acera Surgical Inc. for $725 million in cash plus up to $125 in contingent cash payments based on achievement of specified milestones. St. Louis.-based Acera projected that its synthetic wound care products will bring in $90 million in sales this year.

Avita raises AU$23M to grow Recell wound portfolio

Thu, 14 Aug 2025 12:00:00 -0400

Regenerative medicine company Avita Medical Inc. raised AU$23 million (US$15 million) through a private placement on the Australian Securities Exchange (ASX:AVH) to support growth of its Recell therapeutic acute wound portfolio. Funds raised will support continued growth of the company’s therapeutic acute wound portfolio and will cover operations through 2026.

Tetratherix lists on ASX in $25M IPO

Mon, 30 Jun 2025 12:00:00 -0400

Tetratherix Ltd. raised AU$45 million (US$25 million) in its IPO on the Australian Securities Exchange (ASX:TTX) to support clinical development of its Tetramatrix polymer biomaterial platform to support bone regeneration, tissue spacing and tissue healing.

Device for monitoring wounds without removing dressings

Wed, 18 Jun 2025 12:00:00 -0400

Researchers from the University at Buffalo, the State University of New York (SUNY), filed for protection of their development of a new imaging technology that uses radar and AI to see through dressings to monitor wounds and other skin conditions.

Viromed signs deals for cold plasma technology devices

Fri, 02 May 2025 12:00:00 -0400

Viromed Medical AG recently signed a couple of deals to get its devices based on cold plasma technology into the hands of clinicians to treat patients with skin diseases and pneumological infections.

FDA gives nod to Orthocell’s 510(k) for nerve repair product

Wed, 09 Apr 2025 12:00:00 -0400

The U.S. FDA has cleared regenerative medicine company Orthocell Ltd.’s 510(k) for its nerve repair product, Remplir, paving the way to begin commercial operations in the $1.6 billion U.S. nerve repair market.

New mixed-reality tool created to transform burn care

Fri, 17 Jan 2025 11:00:00 -0500

The U.K.’s Buckinghamshire NHS Trust has partnered medical technology design experts from Team Consulting Ltd. to create a tool that can transform burn care treatment. The concept training tool incorporates mixed reality which maps ‘custom digital burns’ onto a mannequin to enable surgeons to explore a diverse range of burn types and patient profiles and deliver better outcomes.

Renerve raises AU$7M in Australian IPO for nerve repair

Thu, 05 Dec 2024 11:00:00 -0500

After raising AU$7 million (US$4.5 million) in is initial public offering on the Australian Securities Exchange last week, Renerve Ltd. is already exploring mainland China for its portfolio of nerve repair and regeneration products.

Researchers develop coating for surgical sutures to reduce scarring

Thu, 03 Oct 2024 12:00:00 -0400

Researchers from Stanford University have filed for protection of their use of mechanotransduction inhibitors in coatings for surgical sutures to reduce scarring.

AOTI raises £35.1M as it debuts on London’s AIM market

Tue, 18 Jun 2024 12:00:00 -0400

Advanced Oxygen Therapy Inc. raised £35.1 million (US$44.5 million) in its initial public offering on London’s AIM market. The move by the U.S.-based company is a bid to broaden adoption of its chronic wound care technologies.

Drug-device developer Next Biomedical files for Kosdaq IPO

Wed, 12 Jun 2024 12:00:00 -0400

Incheon, South Korea-based Next Biomedical plans to offer one million shares on the Korea Exchange at a price band of ₩24,000 (US$17.42) to ₩29,000 per share. The IPO is scheduled for August 2024 and expected to raise ₩24 billion to ₩29 billion.

Vomaris launches OTC bioelectric bandage for speedier healing

Tue, 16 Apr 2024 12:00:00 -0400

Vomaris Inc. introduced its U.S. FDA-cleared Powerheal bioelectric bandage for over-the-counter use following studies showing a shocking 99.99% reduction in bacteria present in wounds covered with the bandage even without the use of antibiotics. The bandage’s electrical energy also stimulates cell movement, cutting healing time in half, a study found.

FDA clears Stimlabs’ Corplex P for wound care

Fri, 22 Mar 2024 12:00:00 -0400

Stimlabs LLC received U.S. FDA approval for Corplex P, a wound care product that uses placental tissue to facilitate wound healing. “Corplex P is the first particulate device derived from human umbilical cord extracellular matrix indicated for the management of acute and chronic wounds,” Stimlabs CEO John Daniel told BioWorld.

Advanced Medical Solutions buying Peters Surgical for €141.4M

Wed, 13 Mar 2024 12:00:00 -0400

Advanced Medical Solutions Group plc (AMS) signed an agreement to buy Peters Surgical SAS for up to €141.4 million (US$154.6 million). The move by AMS for the tissue repair and skin closure manufacturer is part of its strategy to buy assets which will strengthen its product portfolio and broaden its global reach.

4M Biotech smart dressing for chronic wound management

Fri, 05 Jan 2024 11:00:00 -0500

The first patenting from 4M Biotech Inc. describes a wound dressing with incorporated color-changing pH sensors that are continuously responsive to the pH of wounds or wound exudate.

Study links microbiome, vitamin B12, tissue repair in ulcerative colitis

Fri, 24 Nov 2023 09:00:00 -0500

A laboratory technique used to generate pluripotent stem cells from any tissue, cellular reprogramming, has led a group of researchers to the discovery of a process that could have an impact on natural tissue repair.

Multi-center study gives high marks to pocket-sized wound imaging device

Thu, 14 Sep 2023 12:00:00 -0400

Authors of a multi-center study welcomed results from a device that works with a smartphone or tablet to capture medical images for a more detailed understanding of infected wounds. By capturing heat produced by a wound and using bacterial fluorescence, the Swift Ray 1 developed by Swift Medical Inc., may help clinicians tell the difference between inflammation and a potentially dangerous infection.

Stimlabs’ allograft enables wound drainage and protection

Tue, 05 Sep 2023 10:30:00 -0400

Stimlabs LLC has taken a new view of wound healing by developing a fenestrated dehydrated complete human placental membrane allograft for chronic and acute wounds. The fenestration in the Release product allows fluids to drain away from the wound, promoting faster healing, while the tissue provides protection.

Fesarius receives grant to further develop wound care technology

Mon, 14 Aug 2023 12:00:00 -0400

The $1.83 million grant Fesarius Therapeutics Inc. was recently awarded will allow the company to work on the next generation of dermal repair products to treat complex wounds. The funds from the National Institutes of Health (NIH) will go towards further development of the company’s advanced dermal regeneration scaffold for reconstructive surgery and takes the total amount of non-dilutive grant funding Fesarius has received to develop its hydrogel technology, Dermisphere, to $4 million.

FDA review gels into clearance for plant-based, blood stopping technology

Thu, 13 Jul 2023 12:00:00 -0400

Cresilon Inc. obtained U.S. FDA clearance for a hemostatic gel that staunches the flow of blood from minor external wounds. The Cresilon hemostatic gel (CHG) is the first technology to blend polymers from the algae plant to instantaneously create a mechanical barrier against bleeding.

Coloplast paying up to $1.3B to reel in fish skin tech company

Tue, 11 Jul 2023 12:00:00 -0400

Coloplast A/S agreed to acquire wound care company Kerecis Ehf for up to $1.3 billion in a bid to strengthen its presence in the high-growth, U.S.-centric biologics segment. Kerecis has developed a technology which uses intact fish skin from Atlantic cod to treat chronic wounds. It has around 5% share of the U.S. biologics market.

Silver-infused glass improves wound healing

Mon, 19 Jun 2023 12:00:00 -0400

Saturating bioactive glass with silver sustains the metal’s antimicrobial properties and reduces biofilm formation, researchers at the University of Birmingham, U.K., found. Their study, published in Biofilm, demonstrated that specific preparation, storage and application techniques minimize the transformation of silver ions to silver chloride that typically reduces silver’s healing properties over time.

Merged firms seek lock down of percutaneous wound market with suture holding device

Fri, 24 Feb 2023 13:00:00 -0500

Ra Medical Systems Inc. launched a simple device that holds sutures more securely in place for closure of percutaneous wound sites during cardiac electrophysiology, structural heart and vascular surgical procedures.

Reactivation of fetal protein can lead to improved diabetic wound healing

Fri, 03 Feb 2023 12:00:00 -0500

Researchers at Indiana University School of Medicine are exploring avenues to heal wounds by identifying proteins that are active in fetuses, but largely inactive in adults and absent in diabetic adults. They have identified a protein called nonselenocysteine-containing phospholipid hydroperoxide glutathione peroxidase, or NPGPx, that fits the bill and could be the basis for therapies aimed at diabetic wound healing. NPGPx is a direct transcriptional target of miR-29. miR-29 is downregulated in fetal tissue, thus NPGPx is active in fetal tissue but becomes mostly inactive in the skin after birth.

Reactivation of fetal protein can lead to improved diabetic wound healing

Thu, 02 Feb 2023 09:00:00 -0500

Urgo launching a $107M artificial skin engineering laboratory

Tue, 17 Jan 2023 13:00:00 -0500

Urgo Group SAS has launched, in the presence of the Minister of Health François Braun, the creation of Genesis research laboratory on artificial skin. “Our objective with this novel tissue engineering laboratory is to create artificial skin for helping the health care professionals in the effective treatment of severe wounds and quickly curing the patients,” Guirec Le Lous, CEO of Paris-based Urgo Medical, told BioWorld. Urgo Medical is the advance wound care division of Urgo Group SAS.

Path to scarless healing could be among the gifts reindeer bring

Thu, 05 Jan 2023 12:00:00 -0500

Unlike amphibians, mammals do not regenerate appendages. Except when they do. “If you amputate one of the branches off of the antler [of a reindeer], it will also regenerate,” Jeff Biernaskie told BioWorld. Even without amputation, the antlers of both male and female reindeer regenerate annually, including their skin. That regeneration is “the only large mammal model of true skin regeneration,” he said.

Path to scarless healing could be among the gifts reindeer bring

Wed, 14 Dec 2022 09:00:00 -0500

Rokit wins South Korean approval for diabetic foot ulcers, preps for two IPOs

Thu, 02 Sep 2021 13:00:00 -0400

Rokit Healthcare Inc. received approval from South Korea’s Ministry of Food and Drug Safety (MFDS) for Dfurege, its artificial organ platform to treat diabetic foot ulcers. “We hope that having a South Korean approval for this platform will be a boost for our planned IPO,” Seok Hwan You, CEO at Rokit, told BioWorld.